INOVIQ's exosome technologies enable advanced diagnostics and therapeutics.

INOVIQ has commercialised two products including the EXO-NET^® pan-exosome capture tool for research purposes and the hTERT test for use as an adjunct to urine cytology testing for bladder cancer.

INOVIQ is developing a multi-product including clinical stage EXO-OC™ ovarian cancer screening test and preclinical CAR-exosome therapeutic program.